Hologic v Siemens Healthineers (CFI, 21 May 2025)
| Date | 21 May 2025 |
|---|---|
| Court | CFI |
| Division | Düsseldorf (DE) Local Division |
| Type of action | Generic application |
| Registry reference | App_16529/2025 · ORD_17624/2025 |
| Parties | Siemens Healthcare SAS, Siemens Healthcare GmbH, Siemens Healthineers AG, Siemens Healthineers Nederland B.V. |
Official decision (PDF) · UPC registry entry
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
By order of 21 May 2025, the Düsseldorf Local Division dismissed Siemens’ application for security for costs against Hologic, a US company suing it for infringement of EP 2 352 431 B1 (UPC_CFI_758/2024, with the counterclaim for revocation UPC_CFI_259/2025). The order confirms that a counterclaimant may seek security, but makes clear that difficulty of enforcement abroad must be proven, including the content of the foreign law.
Question
Does Hologic’s domicile in the United States (Massachusetts) make enforcement of a costs order unduly burdensome, so as to justify security of EUR 600,000 per proceeding?
Decision
The Division first held the application admissible: Rule 158.1 is not confined to the defendant in the main action, which disposed of Hologic’s objection to a counterclaimant applying. On the merits, the applicant need not show that enforcement is impossible, only that it would be unduly burdensome, but the burden is on the applicant, who must establish the foreign law and how it is applied. Siemens had offered only argument on Massachusetts law, with no evidence, so the application failed. The Division added that US courts routinely recognise and enforce foreign judgments. It left open the calculation of the amount, while doubting that two ceilings could be applied cumulatively.
Key points for practice
- Security for costs may be sought by a defendant who brings a counterclaim for revocation, including in respect of that counterclaim.
- Practical point: an application based on the absence of a recognition treaty must be supported by evidence of the foreign law and practice, bare assertions will not do.
Provisions applied
- Agreement on a Unified Patent Court
- Art. 69(4)
- Rules of Procedure
- Rule 158.1
- Case law cited
- Munich Local Division, 23 April 2024, UPC_CFI_514/2023, Court of Appeal, 17 September 2024, UPC_CoA_218/2024, Aarke v SodaStream Industries, 29 November 2024, Düsseldorf Local Division, 3 December 2024, UPC_CFI_140/2024
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Going further
Lexicon: Written procedure (UPC), Court fees and costs (UPC).
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Proceedings
Parties
- claimantSiemens Healthcare SAS4 decisions in the corpusFollow this party
- claimantSiemens Healthcare GmbH4 decisions in the corpusFollow this party
- claimantSiemens Healthineers AG4 decisions in the corpusFollow this party
- claimantSiemens Healthineers Nederland B.V.4 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
What the record states
- Nature of the act
- Generic application
- Outcome (Dhenne Avocats summary)
- La division locale de Düsseldorf déclare recevable mais rejette la demande de garantie des frais de Siemens, faute de preuve du droit du Massachusetts et d'une difficulté excessive d'exécution aux États-Unis.
- Appeal
- No appeal documented in the corpus, this does not mean that no appeal was lodged.
- Instance
- First-instance decision, whether it has become final is not recorded.
Patents mentioned
EP 2 352 431mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Aarke v SodaStream Industries (CoA, 29 November 2024) cited in this record
Patents and standards
| Publication | Role in the dispute | Family | Standard and declaration | Pool | Sources |
|---|---|---|---|---|---|
EP 2 352 431 | Mentioned in the analysis (role not qualified) Also mentioned in 4 other decision(s): Hologic v Siemens Healthineers (CFI, 10 June 2026) · Siemens Healthineers v Hologic (CoA, 15 July 2026) · Hologic v Siemens Healthineers (CFI, 9 March 2026) · Hologic v Siemens Healthcare (CFI, 26 August 2025) | not recorded | not recorded | not recorded | Espacenet links not checked mentioned in: Dhenne Avocats analysis |
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.